Table 2.
Correlation Of miR-129 Expression With The Clinicopathological Characteristics Of The NSCLC Patients
| Clinicopathological Features | Cases (n=51) | miR-129a Expression | P-Value | |
|---|---|---|---|---|
| High (n=20) | Low (n=31) | |||
| Age (years) | 0.4356 | |||
| >60 | 29 | 12 | 17 | |
| ≤60 | 22 | 8 | 14 | |
| Gender | 0.4632 | |||
| Male | 27 | 9 | 18 | |
| Female | 24 | 11 | 13 | |
| Tumor size (cm) | 0.2723 | |||
| ≥5.0 | 25 | 6 | 19 | |
| <5.0 | 26 | 14 | 12 | |
| Lymph node metastasis | 0.0014* | |||
| Yes | 21 | 16 | 5 | |
| No | 30 | 4 | 26 | |
| Histology | 0.2932 | |||
| Squamous cell carcinoma | 26 | 11 | 15 | |
| Adenocarcinoma | 25 | 9 | 16 | |
| TNM stage | 0.0021* | |||
| I+II | 23 | 17 | 6 | |
| III+IV | 28 | 3 | 25 | |
| Smoker | 0.5636 | |||
| Yes | 27 | 12 | 15 | |
| No | 24 | 8 | 16 | |
Notes: *Statistically significant. aThe mean expression level of miR-129 was used as the cutoff.
Abbreviations: NSCLC, non-small cell lung cancer; TNM, tumor-node-metastasis.